Conversations in Lung Cancer Research

ALK TKI Sequencing in the Australian Landscape


Listen Later

In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Tim Clay sits down with Australian oncology luminaries Prof Ben Solomon and A/Prof Malinda Itchins to discuss the rapidly evolving landscape of Anaplastic Lymphoma Kinase (ALK) positive lung cancer. Since its discovery in 2007, treatment for this subset of non-small cell lung cancer (NSCLC) has advanced through four generations of inhibitors, significantly improving survival outcomes for the 400–500 Australians diagnosed annually.

(00:00) Welcome and Acknowledgement

(00:43) Meet the Expert Guests

(01:40) ALK History and Breakthroughs

(03:48) Who Gets ALK Lung Cancer

(04:57) Workup and Staging Essentials

(05:54) Patterns of Spread and Clots

(07:24) Second Generation TKIs Standard

(09:03) Long Term Toxicities

(11:07) Progression Assessment and LAT

(12:50) Lorlatinib After Progression

(15:46) Lorlatinib First Line Crown Data

(17:11) Choosing and Dosing Lorlatinib

(20:55) Managing Lorlatinib Side Effects

(22:29) Predicting Response and Follow Up

(29:30) Next Generation Inhibitors NAL

(32:04) Early Stage and Adjuvant TKIs

(36:32) Beyond TKIs Chemo and ADCs

(39:30) Patient Support and Closing

Support TOGA

Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.

---------------

Connect with TOGA

Attend an Event: https://thoraciconcology.org.au/events/

Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/

Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/

Follow Us

LinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/

X (Twitter): https://x.com/TOGAANZ

Instagram: https://www.instagram.com/togaanz/

YouTube:  https://www.youtube.com/@Thoracic_Oncology

---------------

Acknowledgement of Country

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

...more
View all episodesView all episodes
Download on the App Store

Conversations in Lung Cancer ResearchBy Thoracic Oncology Group Of Australasia (TOGA)


More shows like Conversations in Lung Cancer Research

View all
Lung Cancer Considered by IASLC

Lung Cancer Considered

27 Listeners

Lung Cancer Rx by Oncology News Central

Lung Cancer Rx

3 Listeners